MitindomideAlternative Names: NSC 284356
Latest Information Update: 19 Nov 2004
Price : $50
At a glance
- Originator Gulf
- Developer Nonindustrial source
- Class Antineoplastics
- Mechanism of Action DNA inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Nov 2004 Discontinued for Cancer in USA (unspecified route)
- 02 May 1995 This profile is new.
- 02 May 1995 No-Development-Reported for Cancer in USA (Unknown route)